For patients with Lynch syndrome (LS), daily resistant starch (RS) seems to have a lasting protective effect against noncolorectal cancers, according to a study published online July 25 in Cancer Prevention Research.
Aug 18, 2022
0
4
Asthma exacerbations are reduced for children and adolescents with exacerbation-prone eosinophilic asthma who are living in socioeconomically disadvantaged urban neighborhoods and receive mepolizumab therapy, according to ...
Aug 15, 2022
0
6
Long-term follow up of patients with extensive stage small cell lung cancer who were given pembrolizumab and etoposide/platinum (EP) versus placebo + etoposide/platinum as first-line therapy support the continued exploration ...
Aug 9, 2022
0
7
The monoclonal antibodies cinpanemab and prasinezumab show almost no benefit for early Parkinson disease, according to two phase 2 trials published in the Aug. 4 issue of the New England Journal of Medicine.
Aug 4, 2022
0
2
Placebos are fake treatments that are crucial in clinical trials to test if a treatment actually works or whether benefits are merely due to receiving an apparently credible treatment from a trusted clinician. But placebos ...
Aug 4, 2022
0
6
COVID rebound, which struck both President Joe Biden and White House Chief Medical Advisor Dr. Anthony Fauci recently, doesn't just happen in those who take Paxlovid, a new study finds.
Aug 3, 2022
1
4
For patients with COVID-19-related olfactory dysfunction (OD), the clinical benefit of theophylline added to saline nasal irrigation (SNI) is inconclusive, according to a study published online July 7 in JAMA Otolaryngology-Head ...
Jul 29, 2022
0
3
For adults with drug-resistant focal epilepsy, no difference in efficacy was observed at 12 weeks for adjunctive therapy with transdermal cannabidiol versus placebo, according to a study published online July 8 in JAMA Network ...
Jul 18, 2022
0
11
Adding erythropoietin to cooling therapy for term newborns with birth asphyxia has no benefit over cooling therapy alone, a study published today in the New England Journal of Medicine.
Jul 14, 2022
0
3
The National Institutes of Health Clinical Center has begun a phase I trial of a potential universal influenza vaccine, according to an announcement by the agency.
Jul 13, 2022
0
34
